Zentalis Pharma Stock (NASDAQ: ZNTL) stock price, news, charts, stock research, profile.
You can purchase shares of Zentalis Pharma (NASDAQ:ZNTL) through any online brokerage.
Other companies in Zentalis Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Macrogenics (NASDAQ:MGNX), Precigen (NASDAQ:PGEN), Inozyme Pharma (NASDAQ:INZY) and Fate Therapeutics (NASDAQ:FATE).
Zentalis Pharma has a consensus price target of $20.10.
The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $4.0199 last updated November 8, 2024 at 4:44 PM EST.
There are no upcoming dividends for Zentalis Pharma.
Zentalis Pharma’s Q3 earnings are confirmed for Tuesday, November 19, 2024.
There is no upcoming split for Zentalis Pharma.
Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.